FRANCISCO HERNANDEZ: Open Payments
NPI 1619501103 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 13 payments from 7 companies in 2025. Trend: 2023 $530 · 2024 $458 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 3 | $307 |
| Smith+Nephew, Inc. | 4 | $218 |
| Integra LifeSciences Corporation | 2 | $74 |
| GENZYME CORPORATION | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $21 |
Products named: TULA, LIGASURE, STEALTHSTATION S8 PLATFORM, ACCLARENT AERA, DUPIXENT, XOLAIR, NUCALA, NEFFY.
Industry payments across CA — which companies pay providers there.
